BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 23461957)

  • 41. Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans.
    Wolf MS; Fitzner KA; Powell EF; McCaffrey KR; Pickard AS; McKoy JM; Lindenberg J; Schumock GT; Carson KR; Ferreira MR; Dolan NC; Bennett CL
    J Clin Oncol; 2005 Dec; 23(34):8877-83. PubMed ID: 16314648
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
    Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Features of colorectal cancer with fecal-occult-blood tests--comparison with colorectal cancer with no screening].
    Takemasa I; Kikkawa N; Yasui M; Nishisho I; Fujitani K; Mishima H; Hasuike Y; Kobayashi K
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1514-8. PubMed ID: 9725042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is it time to lower the recommended screening age for colorectal cancer?
    Davis DM; Marcet JE; Frattini JC; Prather AD; Mateka JJ; Nfonsam VN
    J Am Coll Surg; 2011 Sep; 213(3):352-61. PubMed ID: 21737316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of repeated screening using the fecal occult blood test and its impact on reducing false-negative cancer cases.
    Nishida H; Urano S
    Eur J Cancer Prev; 2011 May; 20(3):184-9. PubMed ID: 21301345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of advanced neoplasia at screening colonoscopy in men in private practice versus academic and Veterans Affairs medical centers.
    Harewood GC; Lieberman DA
    Am J Gastroenterol; 2003 Oct; 98(10):2312-6. PubMed ID: 14572585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk for colorectal cancer in elderly persons and possible methodologies for their screening.
    Rozen P; Shabtai EI; Liphshitz I; Barchana M
    Eur J Gastroenterol Hepatol; 2011 May; 23(5):431-7. PubMed ID: 21448071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mass screening for colorectal cancer: compliance in Almopea Region.
    Chrissidis T; Saliangas K; Economou A; Nikoloudis N; Andreadis E; Prodromou K; Georgakis K
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s193-5. PubMed ID: 15655620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of various strategies for colorectal cancer screening tests.
    Wohl P; Bednařík M; Wohl P; Cervenka M; Spičák J
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1157-64. PubMed ID: 21989120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
    Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
    Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survival of patients with symptom- and screening-detected colorectal cancer.
    Brenner H; Jansen L; Ulrich A; Chang-Claude J; Hoffmeister M
    Oncotarget; 2016 Jul; 7(28):44695-44704. PubMed ID: 27213584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Screening for colorectal cancer: recommendations].
    Vonlaufen A; Troillet FX; Armenian B
    Rev Med Suisse; 2013 Apr; 9(381):754-7. PubMed ID: 23659152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interval colorectal cancer after colonoscopy.
    Richter JM; Campbell EJ; Chung DC
    Clin Colorectal Cancer; 2015 Mar; 14(1):46-51. PubMed ID: 25510180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screen-detected colorectal cancers show improved cancer-specific survival when compared with cancers diagnosed via the 2-week suspected colorectal cancer referral guidelines.
    Courtney ED; Chong D; Tighe R; Easterbrook JR; Stebbings WS; Hernon J
    Colorectal Dis; 2013 Feb; 15(2):177-82. PubMed ID: 22709315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outpatient colonoscopy complications in the CDC's Colorectal Cancer Screening Demonstration Program: a prospective analysis.
    Castro G; Azrak MF; Seeff LC; Royalty J
    Cancer; 2013 Aug; 119 Suppl 15():2849-54. PubMed ID: 23868479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Advances in CRC Prevention: Screening and Surveillance.
    Dekker E; Rex DK
    Gastroenterology; 2018 May; 154(7):1970-1984. PubMed ID: 29454795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Association Between Primary Source of Healthcare Coverage and Colorectal Cancer Screening Among US Veterans.
    May FP; Yano EM; Provenzale D; Neil Steers W; Washington DL
    Dig Dis Sci; 2017 Aug; 62(8):1923-1932. PubMed ID: 28528373
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estimating the magnitude of colorectal cancers prevented during the era of screening: 1976 to 2009.
    Yang DX; Gross CP; Soulos PR; Yu JB
    Cancer; 2014 Sep; 120(18):2893-901. PubMed ID: 24894740
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Colorectal cancer diagnosis improvement project evaluation demonstrates the importance of using multiple measures to track progress toward timeliness goals.
    Partin MR; Powell AA; Nugent S; Ordin DL
    J Healthc Qual; 2013; 35(3):41-8. PubMed ID: 22192595
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Colorectal cancer: are the "young" being overlooked?
    Taggarshe D; Rehil N; Sharma S; Flynn JC; Damadi A
    Am J Surg; 2013 Mar; 205(3):312-6; discussion 316. PubMed ID: 23414955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.